| Literature DB >> 23137134 |
M Cuenca-Estrella1, P E Verweij, M C Arendrup, S Arikan-Akdagli, J Bille, J P Donnelly, H E Jensen, C Lass-Flörl, M D Richardson, M Akova, M Bassetti, T Calandra, E Castagnola, O A Cornely, J Garbino, A H Groll, R Herbrecht, W W Hope, B J Kullberg, O Lortholary, W Meersseman, G Petrikkos, E Roilides, C Viscoli, A J Ullmann.
Abstract
As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23137134 DOI： 10.1111/1469-0691.12038
Source DB: PubMed Journal: Clin Microbiol Infect ISSN： 1198-743X Impact factor: 8.067